Current Gastroenterology Reports

, Volume 2, Issue 3, pp 210–216 | Cite as

Diagnosis and management of supra-esophageal complications of reflux disease

  • Timothy T. Nostrant
  • John C. Rabine


Supra-esophageal reflux disease may be manifested in numerous ways, including reflux laryngitis, chronic cough, chronic sinusitis, and dental enamel loss. The mechanisms of pharyngeal and laryngeal reflux are not clearly defined, and standard reflux testing does not consistently demonstrate supra-esophageal reflux. The diagnosis is usually based on clinical suspicion when other causes of symptoms are not found and on the patient’s response to empiric acid suppression. With the development of triple-probe pH monitoring, through which pharyngeal pH can be assessed along with esophageal pH, the physician may now be able to demonstrate pharyngeal reflux in relation to patient symptoms. Therapy consists primarily of behavioral modification and aggressive acid suppression, although some alternative therapies exist.


Omeprazole Chronic Cough Laparoscopic Fundoplication Laryngitis Reflux Event 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Ormseth EJ, Wong RKH: Reflux laryngitis: pathophysiology, diagnosis, and management. Am J Gastroenterol 1999, 94:2812–2817. This review is brief and well written and gives a thorough summary of available studies related to reflux laryngitis. The mechanisms and findings of laryngitis are well described.PubMedCrossRefGoogle Scholar
  2. 2.
    Wo JM, Grist WJ, Gussack G, et al.: Empiric trial of high dose omeprazole in patients with posterior laryngitis: a prospective study. Am J Gastroenterol 1997, 92:2160–2165. This prospective study describes 22 patients with posterior laryngitis who were treated with omeprazole. According to this report, approximately 65% of patients responded to therapy, and nearly 40% had a demonstrated relapse off of therapy. Among nonresponders, twicedaily omeprazole dosing was ineffective.PubMedGoogle Scholar
  3. 3.
    Ossakow SJ, Elta G, Colturi T, et al.: Esophageal reflux and dysmotility as the basis for persistent cervical symptoms. Ann Otol Rhinol Laryngol 1987, 96:387–392.PubMedGoogle Scholar
  4. 4.
    Harding SM, Richter JE: The role of gastroesophageal reflux in chronic cough and asthma. Chest 1991, 111:1389–1402.Google Scholar
  5. 5.
    Ness J, Sontag SJ, Schnell T: Prevalence of gastroesophageal reflux in consecutive patients with hoarseness. Gastroenterology 1992, 102:134.Google Scholar
  6. 6.
    KoufmanJA: The otolaryngologic manifestations of gastroesophageal reflux disease: a clinical investigation of 225 patients using 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991, 101:1–78.PubMedCrossRefGoogle Scholar
  7. 7.
    Wo JM, Hunter JG, Waring JP: Dual-channel ambulatory esophageal pH monitoring: a useful diagnostic tool? Dig Dis Sci 1997, 42:2222–2226.PubMedCrossRefGoogle Scholar
  8. 8.
    Waring JP, Lacayo L, Hunter J, et al.: Chronic cough and hoarseness in patients with severe gastroesophageal reflux disease: diagnosis and response to therapy. Dig Dis Sci 1995, 40:1093–1097.PubMedCrossRefGoogle Scholar
  9. 9.
    Ulualp SO, Tohill RJ, Kern M, et al.: Pharyngo-UES contractile reflex in patients with posterior laryngitis. Laryngoscope 1998, 108:1354–1357.PubMedCrossRefGoogle Scholar
  10. 10.
    Fouad YM, Hatlebakk PO, Katz PO, et al.: Elevated upper esophageal sphincter pressure is associated with reflux laryngitis [abstract]. Gastroenterology 1998, G0505:A123.Google Scholar
  11. 11.
    Torrico S, Ren J, Sui Z, et al.: Upper esophageal sphincter function during gastroesophageal reflux events. Gastroenterology 1998, 114:634–681.CrossRefGoogle Scholar
  12. 12.
    Ulualp SO, Tohill R, Shaker R, et al.: Secondary esophageal peristalsis is preserved in patients with posterior laryngitis [abstract]. Gastroenterology 1998, G1291:A316.CrossRefGoogle Scholar
  13. 13.
    Shaw GY, Searl JP: Laryngeal manifestations of gastroesophageal reflux before and after treatment with omeprazole. South Med J 1997, 90:1115–1122.PubMedCrossRefGoogle Scholar
  14. 14.
    Palombini BC, Villanova CAC, Araujo E, et al.: A pathogenic triad in chronic cough: asthma, postnasal drip syndrome, and gastroesophageal reflux disease. Chest 1999, 116:279–284.PubMedCrossRefGoogle Scholar
  15. 15.
    Ours TM, Kavuru MS, Schilz RJ, et al.: A prospective evaluation of esophageal testing and a double blind randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. Am J Gastroenterol 1999, 94:3131–3138. Results from this randomized study indicate that the incidence of reflux-related cough is around 25% and that pH data is not a good predictor of response to proton pump inhibitor (PPI) therapy. The authors recommend a diagnostic approach of ruling out asthma and postnasal drip and then empirically using a 2-week PPI trial.PubMedCrossRefGoogle Scholar
  16. 16.
    Ing AJ, Ngu MC, Breslin ABX: Chronic persistent cough and clearance of esophageal acid. Chest 1992, 102:1668–1671.PubMedGoogle Scholar
  17. 17.
    Rolla G, Colagrande P, Magnano M, et al.: Extrathoracic airway dysfunction in cough associated with gastroesophageal reflux. J Allergy Clin Immunol 1998, 102:204–209.PubMedCrossRefGoogle Scholar
  18. 18.
    Ing AJ, Ngu MC: Cough and gastro-oesophageal reflux [commentary]. Lancet 1999, 353:944–946.PubMedCrossRefGoogle Scholar
  19. 19.
    Irwin S, Madison JM: Anatomical diagnostic protocol in evaluating chronic cough with specific reference to gastroesophageal reflux disease. Am J Med 2000, 108:126S-130S.PubMedCrossRefGoogle Scholar
  20. 20.
    DiBaise JK, Huester JV, Quigley EM: Sinusitis and gastroesophageal reflux disease [letter]. Ann Intern Med 1998, 129:1078.PubMedGoogle Scholar
  21. 21.
    Ulualp SO, Tohill RJ, Hoffman R, Shaker R: Possible relationship of gastroesophagopharyngeal acid reflux with pathogenesis of chronic sinusitis. Am J Rhinol 1999, 13:197–202.PubMedGoogle Scholar
  22. 22.
    Richter JE: Typical and atypical presentations of gastroesophageal reflux disease: the role of esophageal testing in diagnosis and management. Gastroenterol Clin North Am 1996, 25:75–102.PubMedCrossRefGoogle Scholar
  23. 23.
    Schroeder PL, Filler SJ, Ramirez B, et al.: Dental erosion and acid reflux disease. Ann Intern Med 1995, 122:809–815.PubMedGoogle Scholar
  24. 24.
    DeVault KR: Overview of medical therapy for gastroesophageal reflux disease. Gastroenterol Clin North Am 1999, 28:831–845. This excellent review summarizes the major trials, both historic and recent, that have defined current practice guidelines.PubMedCrossRefGoogle Scholar
  25. 25.
    Peghini PL, Katz PO, Castell DO: Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects. Gastroenterology 1998, 115:1335–1339.PubMedCrossRefGoogle Scholar
  26. 26.
    Khoury RM, Katz PO, Hammod R, Castell DO: Bedtime ranitidine does not eliminate the need for a second daily dose of omeprazole to suppress nocturnal gastric pH. Aliment Pharmacol Ther 1999, 13:675–678.PubMedCrossRefGoogle Scholar
  27. 27.
    Williams RBH, Ali GN, Wallace KL, et al.: Esophagopharyngeal acid regurgitation: dual pH monitoring criteria for its detection and insights into mechanisms. Gastroenterology 1999, 117:1051–1061. The pH criteria for defining pharyngeal reflux have not been firmly established. This reported study offers the first significant contribution for this purpose.PubMedCrossRefGoogle Scholar
  28. 28.
    Havast T, Huang S, Levy M, et al.: Posterior pharyngo laryngitis: double blind, randomized, placebo controlled trial of proton pump inhibitor therapy. Aust J Otolaryngol 1999, 3:243–246.Google Scholar
  29. 29.
    Young JL, Shaw GY, Searl JP, Miner PB: Laryngeal manifestations of GERD: endoscopic appearance and management. Gastrointest Endosc 1996, 43:225–230.PubMedCrossRefGoogle Scholar
  30. 30.
    Kamel PL, Hanson D, Kahrilas PJ: Omeprazole for the treatment of posterior laryngitis. Am J Med 1994, 96:321–326.PubMedCrossRefGoogle Scholar
  31. 31.
    Wiener GJ, Copper JB, Wu WC, et al.: Is hoarseness an atypical manifestation of gastroesophageal reflux? An ambulatory 24-hour pH study [abstract]. Gastroenterology 1996, 90:A1691.Google Scholar
  32. 32.
    Richter JE: Extraesophageal presentations of gastroesophageal reflux disease. Semin Gastrointest Dis 1997, 2:75–89. This review article briefly covers all aspects of extra-esophageal reflux with the greatest emphasis on asthma. Of particular interest is its clinical and cost-conscientious approach to management.Google Scholar
  33. 33.
    Goldin GF, Marcinkeiwicz M, Zbroch T, et al.: Esophagoprotective potential of cisapride: an additional benefit for gastroesophageal reflux disease. Dig Dis Sci 1997, 42:1362–1369.PubMedCrossRefGoogle Scholar
  34. 34.
    Allen CJ, Anvari M: Gastro-oesophageal reflux related cough and its response to laparoscopic fundoplication. Thorax 1998, 53:963–968.PubMedCrossRefGoogle Scholar
  35. 35.
    Hunter JG, Trus TL, Branum GD, et al.: A physiologic approach to laparoscopic fundoplication for gastroesophageal reflux disease. Ann Surg 1996, 223:673–685.PubMedCrossRefGoogle Scholar
  36. 36.
    So JBY, Zeiteis SM, Rattner DW.: Outcomes of atypical symptoms attributed to gastroesophageal reflux treated by laparoscopic fundoplication. Surgery 1998, 124:28–32.PubMedGoogle Scholar
  37. 37.
    Hinder RA, Branton SA, Floch NR: Surgical therapy for supraesophageal complications of gastroesophageal reflux disease. In Am J Medicine 2000, 108:178S-180S.CrossRefGoogle Scholar

Copyright information

© Current Science Inc 2000

Authors and Affiliations

  • Timothy T. Nostrant
    • 1
  • John C. Rabine
    • 1
  1. 1.Division of GastroenterologyUniversity of Michigan Medical CenterAnn ArborUSA

Personalised recommendations